Biontech and Genmab's collaboration goes deeper than previously said

The partnership between Genmab and Biontech extends beyond the three current clinical projects evident in their pipelines. The two firms are also collaborating on a number of preclinical candidates that have yet to reach the public’s eye. (Corrected)
Özlemtech, sees partnership opportunities in Denmark beyond the existing collaboration with Danish Genmab | Photo: Biontech/PR
Özlemtech, sees partnership opportunities in Denmark beyond the existing collaboration with Danish Genmab | Photo: Biontech/PR
by ulrich quistgaard, translated by daniel pedersen

(Correction: The article previously stated that the candidate Gen1056 was already in a clinical phase. This now reads that the candidate is headed to clinic).

Already a subscriber?Log in here

Read the whole article

Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

With your free trial you get:

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
Must be at least 8 characters, including three of: Uppercase, lowercase, numbers, symbols
Must contain at least 2 characters
Must contain at least 2 characters

Get full access for you and your coworkers

Start a free company trial today

Share article

Sign up for our newsletter

Stay ahead of development by receiving our newsletter on the latest sector knowledge.

Newsletter terms

Front page now

Further reading